
Preclinical testing at The Ohio State University found Telomir-Zn inhibited growth of canine and human osteosarcoma cell lines, prompting the company to explore a possible in-vivo study in dogs with naturally occurring tumors.
This is a placeholder for a linking article to the 1/2010 VE Click & Copy.
You can glean important information about team members' ambitions and underlying problems by reaching out, one on one, to address how each team member fits into the practice.





